Kyle Jenne

Insider Reports History

Location
Boston, MA
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Kyle Jenne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Jenne:

Company Role Class Num Shares Value Price $ Report Date Ownership
IONIS PHARMACEUTICALS INC EVP, Chf GL Pdt Str Ofcr Restricted Stock Unit 36,677 $1,185,401 $32.32 15 Apr 2025 Direct
IONIS PHARMACEUTICALS INC EVP, Chf GL Pdt Str Ofcr Performance Restricted Stock Units 18,700 $613,472 $32.81 15 Jan 2025 Direct
IONIS PHARMACEUTICALS INC EVP, Chf GL Pdt Str Ofcr Common Stock 11,199 $317,604 $28.36 16 Apr 2025 Direct
IONIS PHARMACEUTICALS INC EVP, Chf GL Pdt Str Ofcr Non-Qualified Stock Option (right to buy) 18,700 02 Jan 2025 Direct

Insider Reports Filed by Kyle Jenne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IONS IONIS PHARMACEUTICALS INC 15 Apr 2025 3 -$85,533 4 EVP, Chf GL Pdt Str Ofcr 17 Apr 2025, 16:53
IONS IONIS PHARMACEUTICALS INC 15 Jan 2025 2 $0 4 EVP, Chf GL Pdt Str Ofcr 17 Jan 2025, 19:40
IONS IONIS PHARMACEUTICALS INC 02 Jan 2025 1 $0 4 EVP, Chf GL Pdt Str Ofcr 06 Jan 2025, 16:55
IONS IONIS PHARMACEUTICALS INC 26 Feb 2024 1 $0 4 EVP, Chf GL Pdt Str Ofcr 13 Mar 2024, 17:52
IONS IONIS PHARMACEUTICALS INC 26 Feb 2024 0 $0 3 EVP, Chf GL Pdt Str Ofcr 13 Mar 2024, 17:52